Forecast: Pharmaceutical Goods Market Size Value in Canada

The pharmaceutical goods market in Canada experienced fluctuations between 2013 and 2023, seeing both sharp declines and a few periods of growth. From 2013 to 2020, the market saw a general downward trend despite occasional growth years like 2018 and 2021. The market value in 2023 was 1.3852 Billion US Dollars, indicating a slight decrease of 0.35% year-on-year.

The last two years showed significant variation with a decline of 9.42% in 2022 followed by a marginal decline in 2023. The compound annual growth rate (CAGR) for the last five years indicated a minimal decrease of 0.46% per year, highlighting the market's struggle in maintaining consistent growth.

From 2024 onwards, forecasts predict a gradually declining trend with a projected 5-year CAGR of -0.32%, suggesting a subtle annual decrease in market value. By 2028, the market is expected to reach 1.3679 Billion US Dollars, highlighting a gradual yet consistent decline.

Future trends to watch for:

• Advancements in healthcare technology and pharmaceuticals that could disrupt current market dynamics.
• Government policies and regulations that could either bolster or impede market growth.
• Global economic factors influencing drug pricing and accessibility in Canada.